1. Home
  2. UONEK vs XLO Comparison

UONEK vs XLO Comparison

Compare UONEK & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

HOLD

Current Price

$1.02

Market Cap

36.9M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.69

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UONEK
XLO
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.9M
41.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UONEK
XLO
Price
$1.02
$0.69
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
27.4K
414.7K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$393,670,000.00
$31,804,000.00
Revenue This Year
N/A
$626.78
Revenue Next Year
N/A
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
588.40
52 Week Low
$0.44
$0.62
52 Week High
$1.40
$1.70

Technical Indicators

Market Signals
Indicator
UONEK
XLO
Relative Strength Index (RSI) 57.55 48.18
Support Level $0.76 $0.63
Resistance Level $1.03 $0.74
Average True Range (ATR) 0.10 0.03
MACD -0.01 0.01
Stochastic Oscillator 58.32 46.87

Price Performance

Historical Comparison
UONEK
XLO

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: